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Massimiliano D’Aiuto, MD,a Giulia Veronesi, MD,a Fedro Alessandro Peccatori, MD,b Giuseppe Pelosi, MD,c
Marco Venturino, MD,d Roberto Gasparri, MD,a Fabio Presicci, MD,a Domenico Galetta, MD,a and
Lorenzo Spaggiari, MD, PhD,a Milan, ItalyWe present a case of a mediastinal-like growingteratoma syndrome (GTS) that occurred in ayoung man after 2 different lines of chemotherapyfailed. The patient was successfully treated with a
complete surgical resection of the giant mediastinal mass.
Clinical Summary
A 30-year-old man with a rapidly growing mediastinal tumor was
referred to our attention after 2 lines of chemotherapy failed. The
patient had been hospitalized 19 months prior for rapid onset of
dyspnea. At that time, a total body computed tomography (CT)
scan revealed an anterior mediastinal mass of 16  8  8 cm. No
evidence of extrathoracic disease was found. Alpha-fetoprotein
(AFP) was 3,027 ng/mL, whereas -human chorionic gonadotro-
pin and serum carcinoembryonic antigen levels were normal. Fine-
needle aspiration of the mediastinal mass revealed a nonsemino-
matous germ cell tumor.
The patient was then submitted to 2 different lines of chemo-
therapy (3 cycles of vinblastine, ifosfamide, and cisplatin [VeIP],
followed by 4 cycles of ifosfamide, carboplatin, and etoposide,
followed by rapid dimensional growth with the appearance of
superior vena cava syndrome, necessitating a multidisciplinary
discussion of the case. Salvage surgery was indicated.
On the patient’s admission to our division, a preoperative
full-body CT scan revealed an increased mediastinal mass, now 20
 19  13 cm in diameter, which was enveloping the superior
vena cava and aortic arch, resulting in almost complete obliteration
of the right hemithorax (Figure 1). The surgical approach under-
taken involved a bilateral anterolateral thoracotomy with trans-
verse sternotomy (“clamshell thoracotomy”) in conjunction with a
partial upper hemisternotomy. The tumor presented a fibrotic cap-
sule apparently intact and firmly attached to the pericardium. Thus,
we performed an extrapericardial resection of the lesion en bloc
with those structures suspected to also be involved, such as the left
brachiocephalic vein, the thymus, the right phrenic nerve, and a
portion of the right inferior pulmonary lobe (Figure 2). Pathologic
examination showed a capsulated germ cell neoplasm of 6 kg,
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228 The Journal of Thoracic and Cardiovascular Surgery ● Julymeasuring 22 19 13 cm, with the following composition: 60%
teratomas, 15% rhabdomyosarcoma, 5% yolk sac-tumor, and 20%
necrotic components. Neither of the resected structures were in-
filtrated by the tumor. The postoperative outcome was uneventful,
and the patient was discharged 11 days after surgery. No adjuvant
therapy was proposed. The patient is still alive 6 months after
surgery, with no evidence of disease indicated at the most recent
chest CT.
Discussion
Primary germ cell tumors of the mediastinum represent 3% to 10%
of all tumors in this location. Most cases occur in patients between
20 and 35 years of age, and the tumor becomes very large before
causing symptoms such as dull retrosternal chest pain, dyspnea, or
superior vena cava syndrome,1 The use of cisplatin-based chemo-
therapy has improved the curability of this tumor, from less than
10% to approximately 80%.2 Serum levels of AFP and -human
chorionic gonadotropin serve as useful biomarkers in the assess-
ment of the response to this therapy. However, after successful
chemotherapy, 3% to 8% of patients present with a relapse, with
growth of the mediastinal mass despite normal serum tumor mark-
ers. This condition was first recognized by Carr et al3 in 1981 and
later by Logothetis4 in 1982, when it was given its current name of
GTS. This clinical pattern must be differentiated from unrespon-
sive teratoma, in which the germ tumor cells maintain their ma-
lignant characteristics, with increasing levels of at least 1 of the
Figure 1. Computed tomography (CT) scan of the chest showing
the mediastinal mass that was enveloping the superior vena cava
and aortic arch, resulting in almost complete obliteration of the
right hemithorax.serum tumor markers.
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2 conditions previously described.
The tumor initially responded to the first 2 cycles of VeIP,
decreasing in both mass size and AFP serum levels (from 3,027.9
ng/mL to 518.8 ng/mL). Then the mass began to grow rapidly,
despite the third cycle of VeIP and the 4 cycles of ifosfamide,
carboplatin, and etoposide, with the serum AFP levels never re-
turning to a normal value. This last situation must be differentiated
from “classic” GTS, because it resulted in a more aggressive and
rapidly evolving clinical pattern requiring salvage surgery. An
unusual combined surgical approach (clamshell thoracotomy with
a partial upper hemisternotomy) was used to obtain both complete
exposure of the mediastinal mass and safe control of the vascular
structures potentially involved. The fact that we were able to
completely resect a mass of such dimensions attests to the excep-
tionality of the procedure performed. These initial results confirm
what the literature has already indicated:5 In wisely selected cases,
Figure 2. Intraoperative field before (A) and after (B) the
LL, left lung; RL, right lung; SVC, superior vena cava; Asalvage surgery is useful in the treatment of mediastinal GTS.
The Journal of ThoraciFurther data are needed to assess the role of possible adjuvant
treatments, especially in those cases in which the pathology shows
a significantly malignant residual component at specimen analysis.
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